Integra LifeSciences

Forecast & Rating13 analysts currently cover Integra LifeSciences, with about 23.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $18.67, about 5.5% downside from the current price of $19.76. Price targets range from $11.00 to $27.00 — a wide spread, showing clear disagreement over just how much Integra LifeSciences can rise. Historically, about 29.8% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Integra LifeSciences's outlook. Data as of Jul 28, 2026; for reference only and not investment advice.